Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ADMA Biologics Inc (NASDAQ:ADMA)

9.32
Delayed Data
As of Jul 31
 +0.34 / +3.79%
Today’s Change
7.51
Today|||52-Week Range
14.00
-16.56%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues1.5M1.4M1.5M1.5M
 
 
 
 
 
Cost of Goods Sold1.7M1.8M2.1M1.8M
 
 
 
 
 
Depreciation And Amortization48.6K54.2K96.8K117.1K
 
 
 
 
 
 
Operating ExpensesGross Income-261.3K-520.1K-677.2K-454.6K
 
 
 
 
 
General Expenses3.3M2.5M3.0M2.7M
 
 
 
 
 
Research And Development1.8M1.5M1.9M1.4M
 
 
 
 
 
Total Operating Expenses5.1M4.4M5.2M4.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.6M-3.0M-3.7M-3.2M
 
 
 
 
 
Extraordinary Credit0.000.000.0067.9K
 
 
Extraordinary Charge-34.8K-14.6K-30.2K0.00
 
 
 
 
Interest Expense On Debt342.8K335.3K381.3K476.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.0M-3.4M-4.1M-3.6M
 
 
 
 
 
Income Taxes0.000.00-551.7K0.00
 
 
Net Income-4.0M-3.4M-3.6M-3.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.3M9.3M9.3M9.9M
 
 
 
 
 
Shares To Calculate EPS Diluted9.3M9.3M9.3M9.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.43-$0.36-$0.38-$0.37
 
 
 
 
 
EPS Diluted-$0.43-$0.36-$0.38-$0.37